Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KNCV Tuberculosis Foundation is a leading international non-profit organization dedicated to the global elimination of tuberculosis (TB). Founded in 1903 and based in the Netherlands, the foundation provides technical assistance, conducts operational research, and implements public health programs in high-burden countries. KNCV focuses on strengthening health systems, improving diagnostic networks, and scaling up effective TB treatments, including for drug-resistant strains. The organization plays a critical role in global policy development and partners with major entities like USAID and the WHO to drive innovation in TB care. Their work encompasses the entire spectrum of TB control, from latent infection to complex multidrug-resistant cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KNCV Tuberculosis Foundation.